Copyright Reports & Markets. All rights reserved.

Global CRISPR And CRISPR-Associated Genes Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Genome Editing
    • 1.2.3 Genetic Engineering
    • 1.2.4 GRNA Database/Gene Librar
    • 1.2.5 CRISPR Plasmid
    • 1.2.6 Human Stem Cells
    • 1.2.7 Genetically Modified Organisms/Crops
    • 1.2.8 Cell Line Engineering
  • 1.3 Market by Application
    • 1.3.1 Global CRISPR And CRISPR-Associated Genes Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Biotechnology Companies
    • 1.3.3 Pharmaceutical Companies
    • 1.3.4 Academic Institutes
    • 1.3.5 Research and Development Institutes
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global CRISPR And CRISPR-Associated Genes Market Perspective (2016-2027)
  • 2.2 CRISPR And CRISPR-Associated Genes Growth Trends by Regions
    • 2.2.1 CRISPR And CRISPR-Associated Genes Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 CRISPR And CRISPR-Associated Genes Historic Market Share by Regions (2016-2021)
    • 2.2.3 CRISPR And CRISPR-Associated Genes Forecasted Market Size by Regions (2022-2027)
  • 2.3 CRISPR And CRISPR-Associated Genes Industry Dynamic
    • 2.3.1 CRISPR And CRISPR-Associated Genes Market Trends
    • 2.3.2 CRISPR And CRISPR-Associated Genes Market Drivers
    • 2.3.3 CRISPR And CRISPR-Associated Genes Market Challenges
    • 2.3.4 CRISPR And CRISPR-Associated Genes Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top CRISPR And CRISPR-Associated Genes Players by Revenue
    • 3.1.1 Global Top CRISPR And CRISPR-Associated Genes Players by Revenue (2016-2021)
    • 3.1.2 Global CRISPR And CRISPR-Associated Genes Revenue Market Share by Players (2016-2021)
  • 3.2 Global CRISPR And CRISPR-Associated Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by CRISPR And CRISPR-Associated Genes Revenue
  • 3.4 Global CRISPR And CRISPR-Associated Genes Market Concentration Ratio
    • 3.4.1 Global CRISPR And CRISPR-Associated Genes Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by CRISPR And CRISPR-Associated Genes Revenue in 2020
  • 3.5 CRISPR And CRISPR-Associated Genes Key Players Head office and Area Served
  • 3.6 Key Players CRISPR And CRISPR-Associated Genes Product Solution and Service
  • 3.7 Date of Enter into CRISPR And CRISPR-Associated Genes Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 CRISPR And CRISPR-Associated Genes Breakdown Data by Type

  • 4.1 Global CRISPR And CRISPR-Associated Genes Historic Market Size by Type (2016-2021)
  • 4.2 Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Type (2022-2027)

5 CRISPR And CRISPR-Associated Genes Breakdown Data by Application

  • 5.1 Global CRISPR And CRISPR-Associated Genes Historic Market Size by Application (2016-2021)
  • 5.2 Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America CRISPR And CRISPR-Associated Genes Market Size (2016-2027)
  • 6.2 North America CRISPR And CRISPR-Associated Genes Market Size by Type
    • 6.2.1 North America CRISPR And CRISPR-Associated Genes Market Size by Type (2016-2021)
    • 6.2.2 North America CRISPR And CRISPR-Associated Genes Market Size by Type (2022-2027)
    • 6.2.3 North America CRISPR And CRISPR-Associated Genes Market Size by Type (2016-2027)
  • 6.3 North America CRISPR And CRISPR-Associated Genes Market Size by Application
    • 6.3.1 North America CRISPR And CRISPR-Associated Genes Market Size by Application (2016-2021)
    • 6.3.2 North America CRISPR And CRISPR-Associated Genes Market Size by Application (2022-2027)
    • 6.3.3 North America CRISPR And CRISPR-Associated Genes Market Size by Application (2016-2027)
  • 6.4 North America CRISPR And CRISPR-Associated Genes Market Size by Country
    • 6.4.1 North America CRISPR And CRISPR-Associated Genes Market Size by Country (2016-2021)
    • 6.4.2 North America CRISPR And CRISPR-Associated Genes Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe CRISPR And CRISPR-Associated Genes Market Size (2016-2027)
  • 7.2 Europe CRISPR And CRISPR-Associated Genes Market Size by Type
    • 7.2.1 Europe CRISPR And CRISPR-Associated Genes Market Size by Type (2016-2021)
    • 7.2.2 Europe CRISPR And CRISPR-Associated Genes Market Size by Type (2022-2027)
    • 7.2.3 Europe CRISPR And CRISPR-Associated Genes Market Size by Type (2016-2027)
  • 7.3 Europe CRISPR And CRISPR-Associated Genes Market Size by Application
    • 7.3.1 Europe CRISPR And CRISPR-Associated Genes Market Size by Application (2016-2021)
    • 7.3.2 Europe CRISPR And CRISPR-Associated Genes Market Size by Application (2022-2027)
    • 7.3.3 Europe CRISPR And CRISPR-Associated Genes Market Size by Application (2016-2027)
  • 7.4 Europe CRISPR And CRISPR-Associated Genes Market Size by Country
    • 7.4.1 Europe CRISPR And CRISPR-Associated Genes Market Size by Country (2016-2021)
    • 7.4.2 Europe CRISPR And CRISPR-Associated Genes Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size (2016-2027)
  • 8.2 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Type
    • 8.2.1 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Application
    • 8.3.1 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Region
    • 8.4.1 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America CRISPR And CRISPR-Associated Genes Market Size (2016-2027)
  • 9.2 Latin America CRISPR And CRISPR-Associated Genes Market Size by Type
    • 9.2.1 Latin America CRISPR And CRISPR-Associated Genes Market Size by Type (2016-2021)
    • 9.2.2 Latin America CRISPR And CRISPR-Associated Genes Market Size by Type (2022-2027)
    • 9.2.3 Latin America CRISPR And CRISPR-Associated Genes Market Size by Type (2016-2027)
  • 9.3 Latin America CRISPR And CRISPR-Associated Genes Market Size by Application
    • 9.3.1 Latin America CRISPR And CRISPR-Associated Genes Market Size by Application (2016-2021)
    • 9.3.2 Latin America CRISPR And CRISPR-Associated Genes Market Size by Application (2022-2027)
    • 9.3.3 Latin America CRISPR And CRISPR-Associated Genes Market Size by Application (2016-2027)
  • 9.4 Latin America CRISPR And CRISPR-Associated Genes Market Size by Country
    • 9.4.1 Latin America CRISPR And CRISPR-Associated Genes Market Size by Country (2016-2021)
    • 9.4.2 Latin America CRISPR And CRISPR-Associated Genes Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size (2016-2027)
  • 10.2 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Type
    • 10.2.1 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Application
    • 10.3.1 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Country
    • 10.4.1 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Details
    • 11.1.2 Thermo Fisher Scientific Business Overview
    • 11.1.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Introduction
    • 11.1.4 Thermo Fisher Scientific Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.1.5 Thermo Fisher Scientific Recent Development
  • 11.2 Editas Medicine
    • 11.2.1 Editas Medicine Company Details
    • 11.2.2 Editas Medicine Business Overview
    • 11.2.3 Editas Medicine CRISPR And CRISPR-Associated Genes Introduction
    • 11.2.4 Editas Medicine Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.2.5 Editas Medicine Recent Development
  • 11.3 Caribou Biosciences
    • 11.3.1 Caribou Biosciences Company Details
    • 11.3.2 Caribou Biosciences Business Overview
    • 11.3.3 Caribou Biosciences CRISPR And CRISPR-Associated Genes Introduction
    • 11.3.4 Caribou Biosciences Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.3.5 Caribou Biosciences Recent Development
  • 11.4 CRISPR therapeutics
    • 11.4.1 CRISPR therapeutics Company Details
    • 11.4.2 CRISPR therapeutics Business Overview
    • 11.4.3 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Introduction
    • 11.4.4 CRISPR therapeutics Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.4.5 CRISPR therapeutics Recent Development
  • 11.5 Intellia therapeutics, Inc.
    • 11.5.1 Intellia therapeutics, Inc. Company Details
    • 11.5.2 Intellia therapeutics, Inc. Business Overview
    • 11.5.3 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Introduction
    • 11.5.4 Intellia therapeutics, Inc. Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.5.5 Intellia therapeutics, Inc. Recent Development
  • 11.6 Cellectis
    • 11.6.1 Cellectis Company Details
    • 11.6.2 Cellectis Business Overview
    • 11.6.3 Cellectis CRISPR And CRISPR-Associated Genes Introduction
    • 11.6.4 Cellectis Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.6.5 Cellectis Recent Development
  • 11.7 Horizon Discovery Plc
    • 11.7.1 Horizon Discovery Plc Company Details
    • 11.7.2 Horizon Discovery Plc Business Overview
    • 11.7.3 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Introduction
    • 11.7.4 Horizon Discovery Plc Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.7.5 Horizon Discovery Plc Recent Development
  • 11.8 Sigma Aldrich
    • 11.8.1 Sigma Aldrich Company Details
    • 11.8.2 Sigma Aldrich Business Overview
    • 11.8.3 Sigma Aldrich CRISPR And CRISPR-Associated Genes Introduction
    • 11.8.4 Sigma Aldrich Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.8.5 Sigma Aldrich Recent Development
  • 11.9 Precision Biosciences
    • 11.9.1 Precision Biosciences Company Details
    • 11.9.2 Precision Biosciences Business Overview
    • 11.9.3 Precision Biosciences CRISPR And CRISPR-Associated Genes Introduction
    • 11.9.4 Precision Biosciences Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.9.5 Precision Biosciences Recent Development
  • 11.10 Genscript
    • 11.10.1 Genscript Company Details
    • 11.10.2 Genscript Business Overview
    • 11.10.3 Genscript CRISPR And CRISPR-Associated Genes Introduction
    • 11.10.4 Genscript Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.10.5 Genscript Recent Development
  • 11.11 Sangamo Biosciences Inc.
    • 11.11.1 Sangamo Biosciences Inc. Company Details
    • 11.11.2 Sangamo Biosciences Inc. Business Overview
    • 11.11.3 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Introduction
    • 11.11.4 Sangamo Biosciences Inc. Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.11.5 Sangamo Biosciences Inc. Recent Development
  • 11.12 Lonza Group Limited
    • 11.12.1 Lonza Group Limited Company Details
    • 11.12.2 Lonza Group Limited Business Overview
    • 11.12.3 Lonza Group Limited CRISPR And CRISPR-Associated Genes Introduction
    • 11.12.4 Lonza Group Limited Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.12.5 Lonza Group Limited Recent Development
  • 11.13 Integrated DNA Technologies
    • 11.13.1 Integrated DNA Technologies Company Details
    • 11.13.2 Integrated DNA Technologies Business Overview
    • 11.13.3 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Introduction
    • 11.13.4 Integrated DNA Technologies Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.13.5 Integrated DNA Technologies Recent Development
  • 11.14 New England Biolabs
    • 11.14.1 New England Biolabs Company Details
    • 11.14.2 New England Biolabs Business Overview
    • 11.14.3 New England Biolabs CRISPR And CRISPR-Associated Genes Introduction
    • 11.14.4 New England Biolabs Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.14.5 New England Biolabs Recent Development
  • 11.15 Origene Technologies
    • 11.15.1 Origene Technologies Company Details
    • 11.15.2 Origene Technologies Business Overview
    • 11.15.3 Origene Technologies CRISPR And CRISPR-Associated Genes Introduction
    • 11.15.4 Origene Technologies Revenue in CRISPR And CRISPR-Associated Genes Business (2016-2021)
    • 11.15.5 Origene Technologies Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    CRISPR And CRISPR-Associated Genes market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CRISPR And CRISPR-Associated Genes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Genome Editing
    Genetic Engineering
    GRNA Database/Gene Librar
    CRISPR Plasmid
    Human Stem Cells
    Genetically Modified Organisms/Crops
    Cell Line Engineering

    Segment by Application
    Biotechnology Companies
    Pharmaceutical Companies
    Academic Institutes
    Research and Development Institutes

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Thermo Fisher Scientific
    Editas Medicine
    Caribou Biosciences
    CRISPR therapeutics
    Intellia therapeutics, Inc.
    Cellectis
    Horizon Discovery Plc
    Sigma Aldrich
    Precision Biosciences
    CRISPR therapeutics
    Intellia therapeutics, Inc.
    Lonza Group Limited
    Integrated DNA Technologies
    New England Biolabs

    Buy now